|
Post by mango on Jun 30, 2020 10:28:34 GMT -5
|
|
|
Post by oldfishtowner on Jun 30, 2020 16:24:39 GMT -5
Technosphere Intl sounds like a trademark for a subsidiary that will develop technosphere based inhaled versions of drugs for clients, providing a good mechanism for extending patent protection for drugs nearing patent expiration or a converting a generic to a patent protected product. I'm assimung the Intl stands for international, but maybe it doesn't.
But if it does, what does this mean for MNKD? Is the company considering taking the route it did with UTHR rather than developing it's own technosphere pipeline, that is, providing a service for others rather than developing a pipeline and looking for partners along the way? Or, both, with on the former, using the UTHR experience as a model?
|
|
|
Post by ktim on Jun 30, 2020 17:03:42 GMT -5
Technosphere Intl sounds like a trademark for a subsidiary that will develop technosphere based inhaled versions of drugs for clients, providing a good mechanism for extending patent protection for drugs nearing patent expiration or a converting a generic to a patent protected product. I'm assimung the Intl stands for international, but maybe it doesn't.
But if it does, what does this mean for MNKD? Is the company considering taking the route it did with UTHR rather than developing it's own technosphere pipeline, that is, providing a service for others rather than developing a pipeline and looking for partners along the way? Or, both, with on the former, using the UTHR experience as a model?
TreT was from MNKD pipeline. They took it through Phase 1. If you take management at face value, they have said that it is the likely model, stating that deals prior to Phase 1 completion usually aren't worth it... and of course we've seen many "partnerships" for pre Phase 1 APIs that haven't been worth the attorney fees to draft the agreements. And as for taking something beyond Phase 1, MNKD doesn't yet have the financial resources to do so. I'm also sure MNKD hasn't been turning away any companies interested in using TS for their own API, as that would seem malfeasance.
|
|